Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 2

1.

A multicenter, double-blind, randomized, placebo-controlled trial of the β3-adrenoceptor agonist solabegron for overactive bladder.

Ohlstein EH, von Keitz A, Michel MC.

Eur Urol. 2012 Nov;62(5):834-40. doi: 10.1016/j.eururo.2012.05.053. Epub 2012 Jun 5.

PMID:
22695239
[PubMed - indexed for MEDLINE]
2.

The grand challenges in cardiovascular drug discovery and development.

Ohlstein EH.

Front Pharmacol. 2010 Sep 23;1:125. doi: 10.3389/fphar.2010.00125. eCollection 2010. No abstract available.

PMID:
21811459
[PubMed]
Free PMC Article

Supplemental Content

Loading ...
Write to the Help Desk